Lakshini Y. Herat
Level 3, Rear 50 Murray St
Perth, WA 6000, Australia
Perth, WA 6000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Recent advances in the approach to catheter-based renal denervation.
Journal: Expert review of medical devices
Published: June 09, 2026
Autonomic control of the vasculature in CKD: leveraging renal denervation.
Journal: Frontiers in neuroscience
Published: April 23, 2026
Combined hepatorenal denervation for hypertension and cardiometabolic disease: a first-in-human study.
Journal: European heart journal
Published: February 17, 2026
Renal denervation in 2026: trial evidence, guideline recommendations and implementation strategies for clinical practice.
Journal: Heart (British Cardiac Society)
Published: October 14, 2025
Targeting renal nerves for arterial hypertension - The path to renal denervation.
Journal: Autonomic neuroscience : basic & clinical
Published: April 04, 2025
The Impact of SGLT2 Inhibitors in the Heart and Kidneys Regardless of Diabetes Status.
Journal: International journal of molecular sciences
Published: August 17, 2023
The Sympathetic Nervous System Regulates Sodium Glucose Co-Transporter 1 Expression in the Kidney.
Journal: Biomedicines
Published: February 20, 2023
Comparing and Contrasting the Effects of the SGLT Inhibitors Canagliflozin and Empagliflozin on the Progression of Retinopathy.
Journal: Frontiers in bioscience (Landmark edition)
Published: February 15, 2023
SGLT1/2 inhibition improves glycemic control and multi-organ protection in type 1 diabetes.
Journal: iScience
Published: September 29, 2022
Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic Retinopathy.
Journal: Frontiers in bioscience (Landmark edition)
Published: July 22, 2022
Last Updated: 09/26/2026